Eradigm has invested in building a purpose-specific AI capability for competitive intelligence, not adapting a generic tool, but co-developing a platform designed from the ground up for the way CI actually works in pharma and biotech. In partnership with Pharosyn, we have built an AI monitoring infrastructure that expands coverage, eliminates noise, and frees our consultants to focus entirely on the judgement and insight that clients pay for.
Governance first
AI adds speed and reach; governance protects accuracy, privacy, and trust. From day one we established clear policies on approved use cases, data handling, vendor selection, and transparency to clients. AI supports, people review, validate, and sign off — so speed never outruns standards.
Purpose-built, not retrofitted
Rather than off-the-shelf solutions, we co-develop tailored technology with Pharosyn, a specialist AI partner. Our tools are built specifically for CI workflows in pharma and biotech, not adapted from generic platforms.
Human accountability at every step
Technology handles triage, signal filtering, and first-draft acceleration. Eradigm consultants own the implications, the context, and the quality sign-off. The client always gets human judgement, not automated output.
Year One Results
80
Less noise
Up to 80% of non-relevant signals filtered out, with full traceability of what is suppressed
50
Less time
Reviewer time reduced by up to 50%, enabling the same team to cover materially more scope with greater rigour
100
Accuracy and speed
Same data sources, faster pick-up time, and no alerts missed to date
Consultant time shifted from signal filtering to implications, decision triggers, and higher-quality client outputs
The roadmap
Contact information
Fill in the contact form and a member of your team will get back to you
info@eradigm.com
Eradigm Consulting
Work.Life
6-7 St Cross St,
London, EC1N 8UB
